22562211000001105: Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual medicinal product\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\UK product\Trade family\Lizinna\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing progesterone receptor agonist (product)\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing norgestimate\Product containing ethinylestradiol and norgestimate\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol and norgestimate\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and norgestimate\Ethinylestradiol + Norgestimate\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing ethinylestradiol and norgestimate\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form)\Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet\Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Jun 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

74241101000001112 Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

74241201000001117 Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Is a	Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has active ingredient	Norgestimate	false	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has specific active ingredient	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has specific active ingredient	Norgestimate	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Is a	Lizinna	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets	Has AMP	True	Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
74241101000001112	Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
74241201000001117	Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module